Chemical proteomics, an integrated research engine for exploring drug-target-phenotype interactions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-5956
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Chemical proteomics, an integrated research engine for exploring drug-target-phenotype interactions ; volume:16 ; number:1 ; day:9 ; month:1 ; year:2018 ; pages:1-2 ; date:12.2018
Proteome science ; 16, Heft 1 (9.1.2018), 1-2, 12.2018
- Schlagwort
-
Arzneimittelentwicklung
Arzneimitteldesign
- Urheber
-
Kwon, Ho Jeong
- Beteiligte Personen und Organisationen
-
Karuso, Peter
SpringerLink (Online service)
- DOI
-
10.1186/s12953-017-0129-x
- URN
-
urn:nbn:de:1111-20180301980
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kwon, Ho Jeong
- Karuso, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Chemical proteomics strategies for elucidation of cellular steroid hormone targets
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors
Off-target identification for a multitarget kinase inhibitor by Chemical Proteomics
Tetrazine ligation for chemical proteomics
Quantitative chemical proteomics reveals that phenethyl isothiocyanate covalently targets BID to promote apoptosis
Improved deconvolution of natural products’ protein targets using diagnostic ions from chemical proteomics linkers
Quantitative chemical proteomics for cancer characterization
Quantitative chemical proteomics for cancer characterization
From compound to target: chemical proteomics and in silico screening identify Hsp90 and CDPK2 as putative targets in Plasmodium falciparum
Benjamin F. Cravatt III – Chemical Proteomics Trailblazer
Chemical proteomics profiling of AMPylation during neuronal differentiation
Chemical proteomics strategies for elucidation of cellular steroid hormone targets
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors
Off-target identification for a multitarget kinase inhibitor by Chemical Proteomics
Tetrazine ligation for chemical proteomics
Quantitative chemical proteomics reveals that phenethyl isothiocyanate covalently targets BID to promote apoptosis
Improved deconvolution of natural products’ protein targets using diagnostic ions from chemical proteomics linkers
Quantitative chemical proteomics for cancer characterization
Quantitative chemical proteomics for cancer characterization
From compound to target: chemical proteomics and in silico screening identify Hsp90 and CDPK2 as putative targets in Plasmodium falciparum
Benjamin F. Cravatt III – Chemical Proteomics Trailblazer
Chemical proteomics profiling of AMPylation during neuronal differentiation
Chemical proteomics strategies for elucidation of cellular steroid hormone targets
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors
Off-target identification for a multitarget kinase inhibitor by Chemical Proteomics
Tetrazine ligation for chemical proteomics
Quantitative chemical proteomics reveals that phenethyl isothiocyanate covalently targets BID to promote apoptosis
Improved deconvolution of natural products’ protein targets using diagnostic ions from chemical proteomics linkers
Quantitative chemical proteomics for cancer characterization
Quantitative chemical proteomics for cancer characterization
From compound to target: chemical proteomics and in silico screening identify Hsp90 and CDPK2 as putative targets in Plasmodium falciparum
Benjamin F. Cravatt III – Chemical Proteomics Trailblazer